Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1982 1
1984 1
1985 1
1986 2
1987 1
1988 4
1989 3
1990 3
1991 2
1992 6
1993 2
1994 5
1995 4
1997 4
1998 10
1999 3
2000 7
2001 8
2002 6
2003 2
2004 7
2005 2
2006 3
2007 5
2008 3
2009 1
2010 1
2011 1
2012 5
2013 3
2014 3
2015 5
2016 5
2017 3
2018 2
2019 5
2021 7
2022 3
2023 2
2024 0

Text availability

Article attribute

Article type

Publication date

Search Results

137 results

Results by year

Filters applied: . Clear all
Page 1
Expanding control of the tumor cell cycle with a CDK2/4/6 inhibitor.
Freeman-Cook K, Hoffman RL, Miller N, Almaden J, Chionis J, Zhang Q, Eisele K, Liu C, Zhang C, Huser N, Nguyen L, Costa-Jones C, Niessen S, Carelli J, Lapek J, Weinrich SL, Wei P, McMillan E, Wilson E, Wang TS, McTigue M, Ferre RA, He YA, Ninkovic S, Behenna D, Tran KT, Sutton S, Nagata A, Ornelas MA, Kephart SE, Zehnder LR, Murray B, Xu M, Solowiej JE, Visswanathan R, Boras B, Looper D, Lee N, Bienkowska JR, Zhu Z, Kan Z, Ding Y, Mu XJ, Oderup C, Salek-Ardakani S, White MA, VanArsdale T, Dann SG. Freeman-Cook K, et al. Among authors: weinrich sl. Cancer Cell. 2021 Oct 11;39(10):1404-1421.e11. doi: 10.1016/j.ccell.2021.08.009. Epub 2021 Sep 13. Cancer Cell. 2021. PMID: 34520734 Free article.
Analysis of lorlatinib analogs reveals a roadmap for targeting diverse compound resistance mutations in ALK-positive lung cancer.
Shiba-Ishii A, Johnson TW, Dagogo-Jack I, Mino-Kenudson M, Johnson TR, Wei P, Weinrich SL, McTigue MA, Walcott MA, Nguyen-Phuong L, Dionne K, Acker A, Kiedrowski LA, Do A, Peterson JL, Barth JL, Yeap BY, Gainor JF, Lin JJ, Yoda S, Hata AN. Shiba-Ishii A, et al. Among authors: weinrich sl. Nat Cancer. 2022 Jun;3(6):710-722. doi: 10.1038/s43018-022-00399-6. Epub 2022 Jun 20. Nat Cancer. 2022. PMID: 35726063 Free PMC article.
Response.
Kim NW, Harley CB, Prowse KR, Weinrich SL, Piatyszek MA, Wright WE, Shay JW. Kim NW, et al. Among authors: weinrich sl. Science. 1995 May 26;268(5214):1116-7. doi: 10.1126/science.268.5214.1116. Science. 1995. PMID: 17840613 No abstract available.
Longitudinal multi-omics study of palbociclib resistance in HR-positive/HER2-negative metastatic breast cancer.
Park YH, Im SA, Park K, Wen J, Lee KH, Choi YL, Lee WC, Min A, Bonato V, Park S, Ram S, Lee DW, Kim JY, Lee SK, Lee WW, Lee J, Kim M, Kim HS, Weinrich SL, Ryu HS, Kim TY, Dann S, Kim YJ, Fernandez DR, Koh J, Wang S, Park SY, Deng S, Powell E, Ravi RK, Bienkowska J, Rejto PA, Park WY, Kan Z. Park YH, et al. Among authors: weinrich sl. Genome Med. 2023 Jul 20;15(1):55. doi: 10.1186/s13073-023-01201-7. Genome Med. 2023. PMID: 37475004 Free PMC article.
Telomerase, cell immortality, and cancer.
Harley CB, Kim NW, Prowse KR, Weinrich SL, Hirsch KS, West MD, Bacchetti S, Hirte HW, Counter CM, Greider CW, et al. Harley CB, et al. Among authors: weinrich sl. Cold Spring Harb Symp Quant Biol. 1994;59:307-15. doi: 10.1101/sqb.1994.059.01.035. Cold Spring Harb Symp Quant Biol. 1994. PMID: 7587082 Review. No abstract available.
Delirium in the older person with cancer.
Weinrich S, Sarna L. Weinrich S, et al. Cancer. 1994 Oct 1;74(7 Suppl):2079-91. doi: 10.1002/1097-0142(19941001)74:7+<2079::aid-cncr2820741716>3.0.co;2-0. Cancer. 1994. PMID: 8087775 Review.
137 results